Spatial navigation ability predicts progression of dementia symptomatology
Spatial navigation ability predicts progression of dementia symptomatology https://flip.it/eV9Piy******************************************Kevin S. McGrew, PhDEducational&School PsychologistDirectorInstitute for Applied Psychometrics (IAP)https://www.themindhub.com******************************************
Purpose of review People with Down syndrome represent the world's largest population with a genetic risk for Alzheimer's disease. This review will provide a short summary of what is known and will include recent findings from the field. Recent findings There has been an increasing focus on biomarker research in this population, with a number of studies presenting findings on promising new markers – Neurofilament Light (NfL) appears to be one such promising marker that has emerged. Imaging studies have increased our knowledge on the progression of Alzheimer's disease in this population. Summary The inclusion o...
Purpose of review Antiamyloid therapy of Alzheimer's disease tackles the overproduction and clearance of the amyloid-beta peptide (Aβ). Immunotherapeutic compounds were tested in large-scale trials. We revisit the recent literature focusing on randomized-controlled trials (RCT) using monoclonal anti-Aβ antibodies. Recent findings Forty-three articles on anti-Aβ passive immunotherapy for Alzheimer's disease were published between January 2016 and October 2019 regarding 17 RCTs: 13 phase III trials using the monoclonal antibodies bapineuzumab, solanezumab, gantenerumab, crenezumab, and aducanumab; three p...
I ’m a cardiology fellow on the frontlines of the COVID-19 pandemic. Like many, I know suffering. In 2017, I lost my father to rapidly progressive dementia. I was postpartum at the time, and he did not even know I was ever pregnant. My stepfather— my father since I was eight years old— the […]Find jobs at Careers by KevinMD.com. Search thousands of physician, PA, NP, and CRNA jobs now. Learn more.
The foods that contained the highest levels of dementia-fighting antioxidants. → Support PsyBlog for just $5 per month. Enables access to articles marked (M) and removes ads. → Explore PsyBlog's ebooks, all written by Dr Jeremy Dean: Accept Yourself: How to feel a profound sense of warmth and self-compassion The Anxiety Plan: 42 Strategies For Worry, Phobias, OCD and Panic Spark: 17 Steps That Will Boost Your Motivation For Anything Activate: How To Find Joy Again By Changing What You Do
Conditions: Obstructive Sleep Apnea; Alzheimer Disease; Vascular Dementia; Mild Cognitive Impairment; Parkinsons Disease With Dementia; Dementia With Lewy Bodies; Mixed Dementia Interventions: Device: In-laboratory polysomnography; Device: Home Sleep Apnea Test Sponsors: Sunnybrook Health Sciences Centre; St. Michael's Hospital, Toronto Recruiting
Conditions: Cognitive Decline; Dementia, Vascular; Alzheimer Disease; Dementia; Stroke Interventions: Other: Behavioral Dietary intervention ( MIND Diet); Other: Behavioral Usual Care Diet Intervention Sponsors: Rush University Medical Center; University of Chicago; Advocate Hospital System; National Institute on Aging (NIA) Not yet recruiting
CONCLUSION: Older adults with non-communicable diseases have high prevalence of cognitive impairment. Physicians should make the patients and their family members aware about the association of non-communicable diseases with cognitive impairments and should encourage these persons to use remedial measures to reduce the risk of future development of dementia. PMID: 32248085 [PubMed - as supplied by publisher]
Conclusion: It is worth educating the public about dementia and developing strategies consistent with their preferences for types of mass media.
AbstractCognition-oriented treatments – commonly categorized as cognitive training, cognitive rehabilitation and cognitive stimulation – are promising approaches for the prevention of cognitive and functional decline in older adults. We conducted a systematic overview of meta-analyses investigating the efficacy of cognition-oriented treatments on cognitive and non-cognitive outcomes in older adults with or without cognitive impairment. Review quality was assessed by A Measurement Tool to Assess Systematic Reviews 2 (AMSTAR). We identified 51 eligible reviews, 46 of which were included in the quantitative synthe...
American Journal of Psychiatry, Ahead of Print.